AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ATRACURIUM

13 registrations across 5 African markets— 6 active

Markets with ATRACURIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
ATRAZED
Injection
🇰🇪KenyaZawadi Healthcare LtdactiveAug 2030
CURARIUM 25
Solution injectable / 10 mg/ml
🇹🇳TunisiaDORCASexpiredJul 2009
CURARIUM 50
Solution injectable / 10 mg/ml
🇹🇳TunisiaDORCASexpiredJul 2009
ATRACURIUM MÉDIS 50
Solution injectable / 50 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredFeb 2006
ATRACURIUM MEDIS 25
Solution injectable / 25 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredFeb 2006
ATRACURIUM MÉDIS 50
Solution injectable / 50 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredDec 2005
ATRACURIUM MÉDIS 25
Solution injectable / 25 mg
🇹🇳TunisiaLES LABORATOIRES MEDISexpiredDec 2005
ATACURE
Solution injectable / 50 mg/5ml
🇹🇳TunisiaHIKMA PharmaceuticalsexpiredDec 2004
TRACRIUM
SOLUTION INJECTABLE
🇲🇦Moroccoactive
TRACRIUM
SOLUTION INJECTABLE
🇲🇦Moroccoactive
Atrium
Injection
🇹🇿TanzaniaSwiss Parenterals Limitedactive
ATRACURIUM
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaTROIKAA PHARMACEUTICA LS LIMITEDactive
ATRACURIUM
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaTROIKAA PHARMACEUTICA LS LIMITEDactive

ATRACURIUM in Africa — Regulatory Overview

ATRACURIUM is registered across 5 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Uganda, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 6 (46%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.